11:10 AM EST, 12/30/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were moving lower late Monday morning, declining 0.92% to 1,284.25 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company Cellectis ( CLLS ) and telecommunications company VEON (VEON), which advanced 12% and 5.8% respectively. They were followed by medical device maker EDAP (EDAP) and petroleum refiner Equinor ( EQNR ) , which rose 2.1% and 0.6% respectively.

The decliners from continental Europe were led by biotech firm Evaxion Biotech ( EVAX ) and biopharmaceutical company Grifols ( GRFS ) , which fell 12% and 4.2% respectively. They were followed by 3D printer company Materialise (MTLS) and furniture maker Natuzzi (NTZ), which were down 3% and 2.6% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical companies TC Biopharm ( TCBP ) and Akari Therapeutics ( AKTX ) , which climbed 11% and 5.5% respectively. They were followed by biopharmaceutical company Biodexa Pharmaceuticals ( BDRX ) and financial services company Lloyds Banking Group ( LYG ) , which were up 3% and 0.2% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company NuCana ( NCNA ) and pharmaceutical company Silence Therapeutics ( SLN ) , which dropped 7.1% and 5.2% respectively. They were followed by biotech firm Trinity Biotech ( TRIB ) and biopharmaceutical company Amarin ( AMRN ) , which lost 3.7% and 2.9% respectively.